Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Pre-Operative Immuno-Modulatory SBRT (POIMS Trial): A Pilot Trial in Early Stage NSCLC
- Status
- WITHDRAWN
- Phase
- NA
Lactobacillus Bifidobacterium V9(Kex02)Improving the Efficacy of Carilizumab Combined With Platinum in Non-small Cell Lung Cancer Patients
- Status
- UNKNOWN
- Phase
- NA
Study of Sacituzumab Govitecan (SG) Versus Docetaxel in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Status
- RECRUITING
- Phase
- N/A
Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies
- Status
- COMPLETED
- Phase
- PHASE2
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Study of Atezolizumab in High PD-L1 Expression, Chemotherapy-Naïve Patients With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Exploration of Immunodynamic Monitoring in the Population Evaluation of Neoadjuvant Chemotherapy Immunotherapy in Patients With Solid Tumors of the Chest.
- Status
- UNKNOWN
- Phase
- PHASE2
A Trial of Camrelizumab Combined With Famitinib Malate in Treatment Naïve Subjects With PD-L1-Positive Recurrent or Metastatic Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus
- Status
- COMPLETED
- Phase
- N/A
Study of Stereotactic Ablative Radiotherapy(SBRT) Followed by Atezolizumab / Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Efficacy of Osimertinib With Early Intervention SRS Treatment Compared to the Continuation of Osimertinib Alone, in Patients With EGFR Mutated NSCLC and Asymptomatic Brain Metastases
- Status
- RECRUITING
- Phase
- NA
Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Evaluation of Genetron Lung Cancer Panel in Non-small Cell Lung Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2